The Wellcome Trust has awarded $8 million to PureTech’s Karuna to take its schizophrenia drug into mid-stage trials. Karuna, which is an affiliate of PureTech Health, was granted the funding ...
The Wellcome Trust is also making a further long-term commitment ... However manufacturing of the drug remains a challenge, and the firm currently has no more supplies to provide for treatment.
The Wellcome Trust now has an asset base of more than £ ... expertise and experience in drug discovery and development, business planning and links with the pharmaceutical and investment communities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback